What does "GLP & incretin research peptide" cover?

Synthetic peptides studied as agonists of the GLP-1, GIP and glucagon receptors. Renuvia Labs lists them with verified identifiers (for example development codes such as LY3298176) and a research profile that states the regulatory status of each compound and the limits of the evidence.

Are these the same as prescription medicines?

No. These vials are research-grade peptides sold for laboratory research use only. They are not approved drugs or compounded medicines, and nothing on the site describes human use. Each product page states the approval status of the related clinical compound for context.

How are they documented?

Each lot is tested for HPLC purity and mass-spectrometry identity and the Certificate of Analysis is published in the [COA library](/coa). A product shows "pending" until its current lot has a report.

GLP & Incretin Research Peptides

GIP, GLP-1 and glucagon receptor agonist peptides supplied as lyophilized powder for laboratory research: Tirzepatide (dual GIP/GLP-1 agonist, LY3298176) and GLP-3-R (triple GIP/GLP-1/glucagon agonist, LY3437943). Each vial is lot-numbered, with the Certificate of Analysis published as reports are received. For laboratory research use only. Not for human or veterinary use.

2 products

Peptides

GLP-3-R

30 mg99.9% purity · Independent labInvestigational

$128.99

In stock · reserve now

Peptides

Tirzepatide

10 mg99.91% purity · Independent labFDA-approved ingredient (Mounjaro 2022, Zepbound 2023)

$114.99

In stock · reserve now

About GLP & Incretin Research Peptides

This collection groups the incretin receptor agonist research peptides in the catalog: Tirzepatide (development code LY3298176), a dual GIP/GLP-1 receptor agonist in a 10 mg vial, and GLP-3-R (development code LY3437943, sometimes written GLP-3), a GIP/GLP-1/glucagon triple agonist in a 30 mg vial. The Tirzepatide listed here is research material, not Mounjaro or Zepbound. Each lyophilized vial is lot-numbered, with its Certificate of Analysis published in the COA library as each lot's report is received. Orders ship within the U.S., and every product is sold for laboratory research use only.

Common questions about glp & incretin research peptides

What does "GLP & incretin research peptide" cover?: Synthetic peptides studied as agonists of the GLP-1, GIP and glucagon receptors. Renuvia Labs lists them with verified identifiers (for example development codes such as LY3298176) and a research profile that states the regulatory status of each compound and the limits of the evidence.
Are these the same as prescription medicines?: No. These vials are research-grade peptides sold for laboratory research use only. They are not approved drugs or compounded medicines, and nothing on the site describes human use. Each product page states the approval status of the related clinical compound for context.
How are they documented?: Each lot is tested for HPLC purity and mass-spectrometry identity and the Certificate of Analysis is published in the COA library. A product shows "pending" until its current lot has a report.